1. Zhang J, Ke Y, Chen C, Jiang Z, Liu H, Liu Y, et al. HPV cancer burden by anatomical site, country, and region in 2022. Sci Rep. 2025;15:21048
https://doi.org/10.1038/s41598-025-06700-8
PMid:40593150 PMCid:PMC12214776

2. Jang W, Kim S, Son Y, Kim S, Lee S, Kim HJ, et al. Global, regional, and national burden of pharyngeal cancer and projections to 2050 in 185 countries: A population-based systematic analysis of GLOBOCAN 2022. J Korean Med Sci. 2025;40:e177
https://doi.org/10.3346/jkms.2025.40.e177
PMid:40762594 PMCid:PMC12322593

3. Mena M, Frias-Gomez J, Taberna M, Quirós B, Marquez S, Clavero O, et al. Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe. Sci Rep. 2020;10:13219
https://doi.org/10.1038/s41598-020-70118-7
PMid:32764593 PMCid:PMC7411067

4. Gatta G, Luttmann S, Trama A, Rossi S, Galceran J, Innos K, et al. Epithelial head and neck cancer survival in Europe: Geographical variation, time trends and long-term survival. Eur J Cancer. 2025;229:115692
https://doi.org/10.1016/j.ejca.2025.115692
PMid:40945302

5. Lorenzoni V, Chaturvedi AK, Vignat J, Laversanne M, Bray F, Vaccarella S. The current burden of oropharyngeal cancer: A global assessment based on GLOBOCAN 2020. Cancer Epidemiol Biomarkers Prev. 2022;31:2054-62
https://doi.org/10.1158/1055-9965.EPI-22-0642
PMid:36173880

6. Duran-Romero AJ, Infante-Cossio P, Pereyra-Rodriguez JJ. Trends in mortality rates for oral and oropharyngeal cancer in Spain, 1979-2018. Oral Dis. 2022;28:336-44
https://doi.org/10.1111/odi.13754
PMid:33305413

7. Carazo-Casas C, Gil-Prieto R, Hernández-Barrera V, Gil de Miguel Á. Trends in hospitalization and death rates among patients with head and neck cancer in Spain, 2009-2019. Hum Vaccin Immunother. 2022;18:2082192
https://doi.org/10.1080/21645515.2022.2082192
PMid:35930449 PMCid:PMC9621082

8. Amezaga-Fernandez I, Marichalar-Mendia X, Lafuente-Ibáñez-de-Mendoza I, López-de-Munain-Marqués A, Aguirre-Urizar JM. Evolution of oral and oropharyngeal cancer in the Basque Country (Spain) from 1986-1994 to 2012-2017. Med Oral Patol Oral Cir Bucal. 2025;30:e925-33
https://doi.org/10.4317/medoral.27518
PMid:41086280 PMCid:PMC12579950

9. Infante-Cossio P, Duran-Romero AJ, Castaño-Seiquer A, Martinez-De-Fuentes R, Pereyra-Rodriguez JJ. Estimated projection of oral cavity and oropharyngeal cancer deaths in Spain to 2044. BMC Oral Health. 2022;22:444
https://doi.org/10.1186/s12903-022-02487-6
PMid:36242042 PMCid:PMC9563172

10. Retegui G, Etxeberria J, Ugarte MD. Estimating LOCP cancer mortality rates in small domains in Spain using its relationship with lung cancer. Sci Rep. 2021;11:22273
https://doi.org/10.1038/s41598-021-01765-7
PMid:34782680 PMCid:PMC8593013

11. Rodrigo JP, Heideman DAM, García-Pedrero JM, Fresno MF, Brakenhoff RH, Díaz Molina JP, et al. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009). Int J Cancer. 2014;134:487-92
https://doi.org/10.1002/ijc.28355
PMid:23824638

12. Rubió-Casadevall J, Ciurana E, Puigdemont M, Sanvisens A, Marruecos J, Miró J, et al. Population-based analysis of trends in incidence and survival of human papillomavirus-related oropharyngeal cancer in a low-burden region of southern Europe. Int J Environ Res Public Health. 2022;19:4802
https://doi.org/10.3390/ijerph19084802
PMid:35457669 PMCid:PMC9027195

13. Blangiardo M, Cameletti M, Baio G, Rue H. Spatial and spatio-temporal models with R-INLA. Spat Spatiotemporal Epidemiol. 2013;4:33-49
https://doi.org/10.1016/j.sste.2012.12.001
PMid:23481252

14. Bosetti C, Carioli G, Santucci C, Bertuccio P, Gallus S, Garavello W, et al. Global trends in oral and pharyngeal cancer incidence and mortality. Int J Cancer. 2020;147:1040-9
https://doi.org/10.1002/ijc.32871
PMid:31953840

15. Ghanem AS, Memon HA, Nagy AC. Evolving trends in oral cancer burden in Europe: A systematic review. Front Oncol. 2024;14:1444326
https://doi.org/10.3389/fonc.2024.1444326
PMid:39493458 PMCid:PMC11527597

16. Goicoa T, Adin A, Ugarte MD, Hodges JS. In spatio-temporal disease mapping models, identifiability constraints affect PQL and INLA results. Stoch Environ Res Risk Assess. 2018;32:749-70
https://doi.org/10.1007/s00477-017-1405-0

17. Zumsteg ZS, Luu M, Rosenberg PS, Elrod JK, Bray F, Vaccarella S, et al. Global epidemiologic patterns of oropharyngeal cancer incidence trends. J Natl Cancer Inst. 2023;115:1544-54
https://doi.org/10.1093/jnci/djad169
PMid:37603716 PMCid:PMC10699798

18. Aragonés N, Ramis R, Pollán M, Pérez-Gómez B, Gómez-Barroso D, Lope V, et al. Oesophageal cancer mortality in Spain: A spatial analysis. BMC Cancer. 2007;7:3
https://doi.org/10.1186/1471-2407-7-3
PMid:17201909 PMCid:PMC1781461

19. Rey-Brandariz J, Ruano-Ravina A, Santiago-Pérez MI, Varela-Lema L, Guerra-Tort C, Montes A, et al. Evolution of smoking prevalence in Spain and its 17 autonomous regions (1987-2020). Med Clin (Barc). 2024;162:417-24
https://doi.org/10.1016/j.medcli.2023.11.015
PMid:38184463

20. Peruga A, Fernández E, Fernández R, Pérez-Ríos M, Rodríguez-Lozano F, Martínez C. Has the reduction in tobacco consumption in Spain stopped? No, but we have to speed it up. Arch Bronconeumol. 2023;59:195-6
https://doi.org/10.1016/j.arbres.2023.02.008
PMid:36863995

21. Córdoba-García R. Fourteen years of tobacco control law in Spain: Current situation and proposals. Aten Primaria. 2020;52:563-9
https://doi.org/10.1016/j.aprim.2020.04.007
PMid:32534759 PMCid:PMC7505859

22. Lechner M, Liu J, Masterson L, Fenton TR. HPV-associated oropharyngeal cancer: Epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol. 2022;19:306-27
https://doi.org/10.1038/s41571-022-00603-7
PMid:35105976 PMCid:PMC8805140

23. Conway DI, Purkayastha M, Chestnutt IG. The changing epidemiology of oral cancer: Definitions, trends, and risk factors. Br Dent J. 2018;225:867-73
https://doi.org/10.1038/sj.bdj.2018.922
PMid:30412558 PMCid:PMC11527597

24. Kokkinis E, Bastas NS, Mega I, Tsironis C, Lianou AD. Association of HPV with oral and oropharyngeal cancer: Current evidence. Maedica (Bucur). 2024;19:801-6
https://doi.org/10.26574/maedica.2024.19.4.801
PMid:39974435 PMCid:PMC11834829

25. World Health Organization. Alcohol and cancer in the WHO European Region: An appeal for better prevention [Internet]. Copenhagen: WHO Regional Office for Europe; 2020. Available from: https://www.who.int/europe/publications/i/item/WHO-EURO-2020-1435-41185-56004

26. Kilian C, Rovira P, Neufeld M, Ferreira-Borges C, Rumgay H, Soerjomataram I, et al. Modelling the impact of increased alcohol taxation on alcohol-attributable cancers in the WHO European Region. Lancet Reg Health Eur. 2021;11:100225
https://doi.org/10.1016/j.lanepe.2021.100225
PMid:34918000 PMCid:PMC8642705

27. Orozco-Acosta E, Riebler A, Adin A, Ugarte MD. A scalable approach for short-term disease forecasting in high spatial resolution areal data. Biom J. 2023;65:e2300096
https://doi.org/10.1002/bimj.202300096
PMid:37890279

28. Nuñez-Vera V, Garcia-Perla-Garcia A, Gonzalez-Cardero E, Esteban F, Infante-Cossio P. Impact of treatment on quality of life in oropharyngeal cancer survivors: A 3-year prospective study. Cancers (Basel). 2024;16:2724
https://doi.org/10.3390/cancers16152724
PMid:39123452 PMCid:PMC11311390

29. Gredner T, Mons U, Niedermaier T, Brenner H, Soerjomataram I. Impact of tobacco control policies implementation on future lung cancer incidence in Europe: An international, population-based modeling study. Lancet Reg Health Eur. 2021;4:100074
https://doi.org/10.1016/j.lanepe.2021.100074
PMid:34029359 PMCid:PMC8121752

30. Retegui G, Etxeberria J, Ugarte MD. Multivariate Bayesian models with flexible shared interactions for analyzing spatio-temporal patterns of rare cancers. Environ Ecol Stat. 2024;31:977-1007
https://doi.org/10.1007/s10651-024-00630-w